Page last updated: 2024-08-24

mibefradil and lacidipine

mibefradil has been researched along with lacidipine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allen, TJ; Cao, Z; Cooper, ME; Hulthén, UL1
Budihna, MV; Drevensek, G; Martinuc, J1
Arh, M; Budihna, MV1

Other Studies

3 other study(ies) available for mibefradil and lacidipine

ArticleYear
Angiotensin converting enzyme inhibition and calcium antagonism attenuate streptozotocin-diabetes-associated mesenteric vascular hypertrophy independently of their hypotensive action.
    Journal of hypertension, 1998, Volume: 16, Issue:6

    Topics: Actins; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Calcium Channels; Diabetes Mellitus, Experimental; Dihydropyridines; Hypertrophy; Male; Mesenteric Arteries; Mibefradil; Muscle, Smooth, Vascular; Peptidyl-Dipeptidase A; Ramipril; Random Allocation; Rats; Rats, Sprague-Dawley; Tetrahydronaphthalenes

1998
Action of mibefradil and lacidipine on the isolated human anterior tibial artery.
    Pflugers Archiv : European journal of physiology, 2000, Volume: 440, Issue:5 Suppl

    Topics: Calcium Channel Blockers; Dihydropyridines; Humans; In Vitro Techniques; Mibefradil; Osmolar Concentration; Potassium Chloride; Tibial Arteries; Vasoconstriction; Vasoconstrictor Agents

2000
Comparison of effects of nitrendipine, lacidipine and mibefradil on postischaemic myocardial damage in isolated rat hearts.
    Pflugers Archiv : European journal of physiology, 2000, Volume: 440, Issue:5 Suppl

    Topics: Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Coronary Circulation; Dihydropyridines; Female; Heart; Hemodynamics; In Vitro Techniques; Male; Mibefradil; Myocardial Ischemia; Myocardial Reperfusion Injury; Nitrendipine; Pressure; Rats; Rats, Wistar; Reference Values; Ventricular Function, Left

2000